|
C6ORF186 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.137900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.897800E-01 |
| Normal-vs-Stage2 |
5.081900E-02 |
| Normal-vs-Stage3 |
3.623700E-02 |
| Normal-vs-Stage4 |
1.65530000817427E-09 |
| Stage1-vs-Stage2 |
7.548100E-02 |
| Stage1-vs-Stage3 |
3.210000E-02 |
| Stage1-vs-Stage4 |
5.54180035194918E-11 |
| Stage2-vs-Stage3 |
8.679200E-01 |
| Stage2-vs-Stage4 |
7.200400E-03 |
| Stage3-vs-Stage4 |
5.648300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.587500E-02 |
| Normal-vs-AfricanAmerican |
7.384900E-03 |
| Normal-vs-Asian |
9.216800E-01 |
| Caucasian-vs-AfricanAmerican |
1.385040E-01 |
| Caucasian-vs-Asian |
6.836200E-01 |
| AfricanAmerican-vs-Asian |
2.940800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.222600E-04 |
| Normal-vs-Female |
7.638800E-01 |
| Male-vs-Female |
4.042700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.043300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.082370E-01 |
| Normal-vs-Age(61-80Yrs) |
4.776400E-02 |
| Normal-vs-Age(81-100Yrs) |
8.032600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.632390E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.882500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.226240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.328400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.556000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.494800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.243800E-01 |
| Normal-vs-Grade 2 |
7.082000E-01 |
| Normal-vs-Grade 3 |
8.055900E-02 |
| Normal-vs-Grade 4 |
1.82210002641625E-09 |
| Grade 1-vs-Grade 2 |
9.838200E-01 |
| Grade 1-vs-Grade 3 |
4.301200E-01 |
| Grade 1-vs-Grade 4 |
1.098520E-03 |
| Grade 2-vs-Grade 3 |
1.340390E-01 |
| Grade 2-vs-Grade 4 |
7.42639949535828E-10 |
| Grade 3-vs-Grade 4 |
4.24089999995214E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.319900E-02 |
| Normal-vs-ccB subtype |
1.53303999999022E-05 |
| ccA subtype-vs-ccB subtype |
3.42337269643167E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.164000E-01 |
| Normal-vs-N1 |
3.96839999999843E-05 |
| N0-vs-N1 |
1.282280E-03 |
|
|
